Your browser is no longer supported. Please, upgrade your browser.
Settings
BLU [NASD]
BELLUS Health Inc.
Index- P/E- EPS (ttm)-0.64 Insider Own3.30% Shs Outstand78.34M Perf Week53.83%
Market Cap451.59M Forward P/E- EPS next Y-0.73 Insider Trans0.00% Shs Float70.96M Perf Month90.22%
Income-46.80M PEG- EPS next Q-0.22 Inst Own69.19% Short Float1.61% Perf Quarter78.93%
Sales0.01M P/S30105.78 EPS this Y1.90% Inst Trans-0.03% Short Ratio0.63 Perf Half Y44.60%
Book/sh1.49 P/B4.05 EPS next Y- ROA-34.60% Target Price- Perf Year152.30%
Cash/sh0.97 P/C6.24 EPS next 5Y- ROE-36.50% 52W Range2.01 - 6.34 Perf YTD97.06%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-4.89% Beta0.12
Dividend %- Quick Ratio8.00 Sales past 5Y- Gross Margin- 52W Low200.00% ATR0.44
Employees32 Current Ratio8.00 Sales Q/Q0.00% Oper. Margin- RSI (14)86.54 Volatility21.41% 9.68%
OptionableYes Debt/Eq0.00 EPS Q/Q-63.00% Profit Margin- Rel Volume1.01 Prev Close5.79
ShortableYes LT Debt/Eq0.00 EarningsAug 11 AMC Payout- Avg Volume1.81M Price6.03
Recom- SMA2051.93% SMA5078.82% SMA20067.42% Volume1,831,848 Change4.15%
Jul-29-21Initiated BTIG Research Buy $9
Jan-29-21Initiated RBC Capital Mkts Outperform $8
Nov-18-20Initiated Evercore ISI Outperform $12
Jul-07-20Downgrade Guggenheim Buy → Neutral
Jun-26-20Initiated H.C. Wainwright Buy $28
Sep-30-19Initiated Jefferies Buy $20
Sep-30-19Initiated Guggenheim Buy $12
Sep-30-19Initiated Cowen Outperform
Sep-15-21 10:32AM  
Sep-14-21 02:49PM  
12:27PM  
12:04PM  
Sep-13-21 11:02AM  
07:45AM  
Sep-12-21 08:09AM  
Sep-02-21 07:00AM  
Aug-23-21 07:00AM  
Aug-11-21 04:30PM  
Jul-14-21 02:41AM  
May-25-21 09:04AM  
07:00AM  
May-18-21 09:10AM  
May-17-21 11:15AM  
10:22AM  
09:07AM  
01:10AM  
May-16-21 03:21PM  
02:30PM  
10:00AM  
May-15-21 09:36PM  
12:44PM  
10:25AM  
05:03AM  
May-14-21 04:49PM  
03:20PM  
03:15PM  
02:20PM  
01:39PM  
12:10PM  
11:00AM  
10:41AM  
05:49AM  
May-13-21 10:00PM  
04:00PM  
03:20PM  
01:55PM  
01:00PM  
11:45AM  
11:00AM  
10:44AM  
06:15AM  
05:00AM  
May-12-21 07:51PM  
04:50PM  
03:20PM  
02:48PM  
01:15PM  
11:10AM  
11:00AM  
10:00AM  
09:00AM  
07:20AM  
07:00AM  
06:10AM  
May-11-21 06:34PM  
01:20PM  
12:30PM  
11:40AM  
11:00AM  
10:56AM  
May-10-21 07:45PM  
05:09PM  
04:30PM  
02:53PM  
01:00PM  
12:00PM  
10:55AM  
10:35AM  
10:00AM  
07:00AM  
06:20AM  
May-08-21 08:55PM  
May-07-21 02:30PM  
02:05PM  
May-06-21 11:45AM  
11:00AM  
06:30AM  
May-05-21 10:38PM  
10:01PM  
10:45AM  
10:14AM  
May-04-21 11:30AM  
11:00AM  
11:00AM  
May-03-21 04:51PM  
03:12PM  
12:35PM  
12:00PM  
06:30AM  
May-02-21 11:52PM  
Apr-30-21 09:22PM  
10:35AM  
10:00AM  
Apr-29-21 06:10PM  
05:22PM  
12:45PM  
12:00PM  
10:25AM  
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.